A new cancer care dilemma: Patients want immunotherapy even when evidence is lacking

JUNE 4, 2018

New immunotherapy treatments have sparked significant hope about cancer care. But they’ve also created a dilemma for doctors: Their patients, citing television adsand stories in the news about miraculous recoveries, are pushing to try them, even when there isn’t much evidence the drugs will work for their cancer. And many of the treatments bring risky side effects and high price tags. Physicians want to give patients every chance at survival, but can they justify prescribing a treatment that hasn’t been tested for a patient’s particular type of cancer? STAT’s Casey Ross has the story here.